JO3333B1 - Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes - Google Patents
Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetesInfo
- Publication number
- JO3333B1 JO3333B1 JOP/2014/0244A JOP20140244A JO3333B1 JO 3333 B1 JO3333 B1 JO 3333B1 JO P20140244 A JOP20140244 A JO P20140244A JO 3333 B1 JO3333 B1 JO 3333B1
- Authority
- JO
- Jordan
- Prior art keywords
- dimethylpropan
- aminium
- carboxy
- ethyl
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Abstract
Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium and its pharmaceutically acceptable salts to decrease blood plasma levels of insulin and glucose.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13186201 | 2013-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
JO3333B1 true JO3333B1 (en) | 2019-03-13 |
Family
ID=49231372
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2014/0244A JO3333B1 (en) | 2013-09-26 | 2014-08-05 | Use of 3-carboxy-N-ethyl-N,N-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes |
Country Status (9)
Country | Link |
---|---|
CN (1) | CN105530929B (en) |
AR (1) | AR099638A1 (en) |
BR (1) | BR112016004211B1 (en) |
CA (1) | CA2924682C (en) |
JO (1) | JO3333B1 (en) |
MX (1) | MX368505B (en) |
TN (1) | TN2016000064A1 (en) |
WO (1) | WO2015044828A1 (en) |
ZA (1) | ZA201600894B (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2067474A1 (en) * | 2007-12-05 | 2009-06-10 | Grindeks, a joint stock company | Medical use of 3-(2,2,2-trimethylhydrazinium) propionate hydrogen fumarate |
LV14345B (en) * | 2009-10-22 | 2011-07-20 | Grindeks, A/S | 4-[ethyl(dimethyl)ammonio]butanoate and their use in the treatment of cardiovascular diseases |
JP5997762B2 (en) | 2011-04-27 | 2016-09-28 | グリンデクス, ア ジョイント ストック カンパニーGRINDEKS, a joint stock company | Use of 3-carboxy-N-ethyl-N, N-dimethylpropane-1-aminium salt in the treatment of cardiovascular disease |
-
2014
- 2014-08-05 JO JOP/2014/0244A patent/JO3333B1/en active
- 2014-08-13 AR ARP140103039A patent/AR099638A1/en unknown
- 2014-09-15 TN TN2016000064A patent/TN2016000064A1/en unknown
- 2014-09-15 CN CN201480050485.3A patent/CN105530929B/en active Active
- 2014-09-15 BR BR112016004211-5A patent/BR112016004211B1/en active IP Right Grant
- 2014-09-15 MX MX2016003347A patent/MX368505B/en active IP Right Grant
- 2014-09-15 CA CA2924682A patent/CA2924682C/en active Active
- 2014-09-15 WO PCT/IB2014/064514 patent/WO2015044828A1/en active Application Filing
-
2016
- 2016-02-09 ZA ZA2016/00894A patent/ZA201600894B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2016003347A (en) | 2016-06-24 |
CN105530929A (en) | 2016-04-27 |
TN2016000064A1 (en) | 2017-07-05 |
CA2924682A1 (en) | 2015-04-02 |
BR112016004211A2 (en) | 2017-08-01 |
BR112016004211B1 (en) | 2022-09-06 |
CA2924682C (en) | 2018-02-27 |
WO2015044828A1 (en) | 2015-04-02 |
ZA201600894B (en) | 2017-05-31 |
CN105530929B (en) | 2018-03-02 |
AR099638A1 (en) | 2016-08-10 |
MX368505B (en) | 2019-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015500115B1 (en) | Glucagon analogues | |
PH12014501997A1 (en) | Esketamine for the treatment of treatment-refractory or treatment-resistant depression | |
MX356728B (en) | Pharmaceutical combination for use in the treatment of diabetes type 2. | |
GB201314512D0 (en) | Dual Haemodialysis and Haemodiafiltration blood treatment device | |
SA517381678B1 (en) | Dihydropyrimidin-2-One Compounds and Medical Use Thereof | |
HK1223529A1 (en) | Low glucose treatment for people with diabetes | |
MX2016011881A (en) | Dry-powder peptide medicament. | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
WO2014152754A3 (en) | Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens | |
PH12016500950A1 (en) | Infant nutrition for improvement in insulin sensitivity later in life | |
TN2016000064A1 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes | |
MX2013009456A (en) | Vinyl -aryl - sulfones for use in peritoneal carcinomatosis. | |
SI2699545T1 (en) | Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome | |
SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
PH12015500306A1 (en) | Arry-520 for use in treating cancer in a patient with low aag | |
PL2852400T3 (en) | An insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes | |
AU2014903587A0 (en) | Regulation of a blood glucose level in a patient with diabetes | |
PH12015500178A1 (en) | Injectable supersaturated acetaminophen solution for spinal administration | |
IN2014DE00818A (en) | ||
UA74052U (en) | Method for preventing lateral abdominal wall hernia in patients with functioning colostoma and ventral hernia | |
GB201304462D0 (en) | Therapeutic vaccine for treatment of type 2 diabetes and impaired glucose tolerance | |
UA97741C2 (en) | Method for regeneration of skin integuments in patients with deep burns by microautodermotransplants | |
UA79303U (en) | use of taurine as agent for stabilizing the concentration in blood plasma in the treatment of fungal diseases | |
UA84195U (en) | Method for treating influenza in adult patients | |
UA97054C2 (en) | Method for the treatment of patients with dependence owing to application of psychoactive substances |